Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Taiwan / NCT07121283
Enrolling by invitation Not applicable

Artificial Intelligence Assisted Bone Age Assessment

NCT07121283 · tracked via the Priya Life Science Taiwan tracker
Sponsor
Cheng-Hsin General Hospital
Phase
Not applicable
Started
2025-09-01
Last updated
2026-04-17

Condition(s) studied

Bone Age

Investigational drug(s) / intervention(s)

True AIFake AI

True AI: True output from bone age AI

Fake AI: Randomized output from bone age AI

Study summary

AI-Assisted Bone Age Assessment

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Exams read by radiologists who interpret pediatric skeletal age exams and verbally consent to participate Exclusion Criteria: * Exams containing more than one radiograph will not be included. No further exclusion criteria will be applied on the basis of image quality metrics or manufacturers

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Cheng Hsin General Hospital Taipei Taiwan

More Cheng-Hsin General Hospital trials in Taiwan

Acupoint Stimulation Improves Postoperative Wound Pain Enrolling by invitation
Gait Training for Hemiplegic Stroke Patients With Stationary Trainer Enrolling by invitation
Automated Trainer-Based Gait Rehabilitation for Hemiplegic Stroke Patients Enrolling by invitation
rTMS Combined With Aerobic Exercise for Older Adults With Mild Cognitive Impairment and Comorbid Depression Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07121283 on ClinicalTrials.gov ↗ ← All trials in Taiwan